Sheen, Y. (2022) “Co-treatment with Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer: ALK5 inhibitor suppressed radiation induced metastasis”, Radiology and Oncology, 56(2), pp. 185–197. Available at: https://radioloncol.com/index.php/ro/article/view/3779 (Accessed: 10 June 2026).